Biblio

Export 624 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
2024
B. Polis and Samson, A. O., Addressing the Discrepancies Between Animal Models and Human Alzheimer's Disease Pathology: Implications for Translational Research., J Alzheimers Dis, vol. 98, no. 4, pp. 1199-1218, 2024.
F. Rajabli, Seixas, A. A., Akgun, B., Adams, L. D., Inciute, J., Hamilton, K. L., Whithead, P. G., Konidari, I., Gu, T., Arvizu, J., Golightly, C. G., Starks, T. D., Laux, R., Byrd, G. S., Haines, J. L., Beecham, G. W., Griswold, A. J., Vance, J. M., Cuccaro, M. L., and Pericak-Vance, M. A., African Ancestry Individuals with Higher Educational Attainment Are Resilient to Alzheimer's Disease Measured by pTau181., J Alzheimers Dis, vol. 98, no. 1, pp. 221-229, 2024.
S. M. de la Monte and Tong, M., Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration., J Alzheimers Dis, vol. 97, no. 4, pp. 1703-1726, 2024.
R. Ali Syed, Hayat, M., Qaiser, H., Uzair, M., Al-Regaiey, K., Khallaf, R., Kaleem, I., and Bashir, S., Aging-Related Protein Alterations in the Brain., J Alzheimers Dis, vol. 99, no. s1, pp. S5-S22, 2024.
S. J. Czuczwar, Kocki, J., Miziak, B., Bogucki, J., Bogucka-Kocka, A., and Pluta, R., Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer's Disease with Survival up to 2 Years., J Alzheimers Dis, vol. 98, no. 1, pp. 151-161, 2024.
A. Noori, Jayakumar, R., Moturi, V., Li, Z., Liu, R., Serrano-Pozo, A., Hyman, B. T., and Das, S., Alzheimer DataLENS: An Open Data Analytics Portal for Alzheimer's Disease Research., J Alzheimers Dis, vol. 99, no. s2, pp. S397-S407, 2024.
A. Aljassabi, Zieneldien, T., Kim, J., Regmi, D., and Cao, C., Alzheimer's Disease Immunotherapy: Current Strategies and Future Prospects., J Alzheimers Dis, vol. 98, no. 3, pp. 755-772, 2024.
H. M. Lalive, Griffa, A., Carlier, S., Nasuti, M., Di Noto, T., Maréchal, B., Rouaud, O., and Allali, G., Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease., J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
K. Noorda, Noorda, K., Sabbagh, M. N., Bertelson, J., Singer, J., and Decourt, B., Amyloid-Directed Antibodies: Past, Present, and Future., J Alzheimers Dis, vol. 101, no. s1, pp. S3-S22, 2024.
R. W. B. Love, Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer's Disease., J Alzheimers Dis, vol. 98, no. 4, pp. 1235-1241, 2024.
R. Pluta, Bogucka-Kocka, A., Bogucki, J., Kocki, J., and Czuczwar, S. J., Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer's Disease with 2-Year Survival., J Alzheimers Dis, vol. 99, no. 4, pp. 1375-1383, 2024.
D. A. Loeffler, Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems., J Alzheimers Dis, vol. 100, no. 2, pp. 379-411, 2024.
T. Nagata, Nakajima, S., Kito, S., and Shinagawa, S., The Association Between Distinct Delusional Ideations and Depressive Symptoms in Alzheimer's Disease: A Re-Analysis of CATIE-AD., J Alzheimers Dis, vol. 101, no. 2, pp. 661-670, 2024.
J. Ren, Yu, Y., Wang, Y., Dong, Y., and Shen, X., Association Between Urinary Glyphosate Exposure and Cognitive Impairment in Older Adults from NHANES 2013-2014., J Alzheimers Dis, vol. 97, no. 2, pp. 609-620, 2024.
X. - X. Zhang, Wang, H. - R., Hu, Y. - Z., Sun, H. - M., Feng, Y. - X., and Jia, J. - J., Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies., J Alzheimers Dis, vol. 98, no. 2, pp. 373-385, 2024.
Z. Li, Fan, Z., and Zhang, Q., The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
J. R. M. Coimbra, Resende, R., Custódio, J. B. A., Salvador, J. A. R., and Santos, A. E., BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives., J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
I. J. Sible and Nation, D. A., Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial., J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
W. B. Grant, A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease., J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
Y. Zeng, Cao, S., Pang, K., Tang, J., and Lin, G., Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study., J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
P. P. Chum, Bishara, M. A., Solis, S. R., and Behringer, E. J., Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation., J Alzheimers Dis, vol. 99, no. s2, pp. S187-S234, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease., J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
I. Terao and Kodama, W., Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.

Pages